As per DelveInsight estimates, North America is anticipated to dominate the global biologics drug substance manufacturing market during the forecast period. In the biologics type segment of the ...

The global spine biologics market is on pace to have a 17.51% compound annual growth rate from 2024 to 2034, according to a Jan. 31 news release from Researchan ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase is Your Competitive Edge Tod ...

Digital Biomanufacturing Market Forecasts to 2035: 140+ Platforms, based on PAT, DAS, MES, Digital Twins and other Technologies, are being Offered for Digitalization of the Biologic Production Process ...

Market OverviewThe Global Generic Drugs Market was valued at $411.99 Billion in 2022 and is projected to reach $613.34 ...

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

and accessible for global patient needs. In 2024, North America held the largest share of the biologics drug substance manufacturing market among all regions. This growth is primarily fueled by a ...

Key Takeaways from the Biologics Drug Substance Manufacturing Market Report As per DelveInsight estimates, North America is anticipated to dominate the global ... This growth is primarily fueled ...

As per DelveInsight estimates, North America is anticipated to dominate the global biologics drug substance manufacturing market during the forecast period. In the biologics type segment of the ...